Recall Register

Drug recall: Synthroid (levothyroxine sodium) Tablets USP, 50 mcg, Rx Only, 90-Count Bottle, Abbott Laboratories, North Chicago, IL…

Class II FDA enforcement event 62674. Recall start date: . Status in the FDA record: Terminated. Termination date: .

Reason for recall, in the words of FDA

Defective Container: A number of Synthroid bottles have a localized thin wall defect on the bottom which may potentially impact the stability of the tablets.

Class II, in the words of FDA

a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote

Abbott Laboratories started this drug recall on 19 Jul 2012. The firm address in the FDA record is in Abbott Park, IL. FDA put the recall in Class II. FDA event 62674 has 3 product records. The first FDA enforcement report date is 3 Oct 2012. The record gives the status Terminated, with the termination date 1 Nov 2013.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Distribution

In the words of FDA.

Nationwide

Recalling firm

Abbott Laboratories, Abbott Park, IL.

Recalling firm: The firm that the FDA record names for a recall.

FDA records how the recall started: Voluntary: Firm initiated.

Products

3 product records in the event.

FDA event 62674: product records
Recall numberProductQuantityClassStatusReport date
D-1694-2012Synthroid (levothyroxine sodium) Tablets USP, 50 mcg, Rx Only, 90-Count Bottle, Abbott Laboratories, North Chicago, IL 60064, NDC: 0074-4552-90.53,448 BottlesClass IITerminated3 Oct 2012
D-1695-2012Synthroid (levothyroxine sodium) Tablets USP, 75 mcg, Rx Only, 90-Count Bottle, Abbott Laboratories, North Chicago, IL 60064, NDC: 0074-5182-90.42,596 BottlesClass IITerminated3 Oct 2012
D-1696-2012Synthroid (levothyroxine sodium) Tablets USP, 112 mcg, Rx Only, 90-Count Bottle, Abbott Laboratories, North Chicago, IL 60064, NDC: 0074-9296-9040,464 BottlesClass IITerminated3 Oct 2012

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Class II: The middle of the three FDA recall classes.

The event in context

Drug events that started in 2012
209
Share of these events in Class II
56%
Product records in this event
3Median of the firm: 1
Events of the firm on the register
46

Other events of the firm

Official channels

Cite this page

Recall Register. FDA enforcement event 62674. https://recallregister.com/fda/ii/62674/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA drug enforcement reports
Licence
CC0 1.0
Export date
28 Sep 2026
Newest FDA report date on the register
23 Sep 2026

FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.

Questions

Where was the product distributed?
The FDA record gives this distribution: Nationwide
What quantity of product is in FDA event 62674?
The event has 3 product records. The first record gives this quantity: 53,448 Bottles
How did the recall start?
The FDA record says: Voluntary: Firm initiated
How many drug recalls of 2012 have the same class?
56% of the 209 drug events that started in 2012 are in Class II.